Union Minister Jitendra Singh recently inaugurated a cellular therapy facility at Delhi’s Institute of Liver and Biliary Sciences. Notably, this development represents a major leap forward for advanced cell-based therapeutic applications in India. Furthermore, the establishment of this current good manufacturing practice (cGMP) setup will directly strengthen clinical research. During the inaugural event, ILBS also proposed a national centre for liver and metabolic diseases. Specifically, this centre would integrate clinical care, scientific research, and public health education under one umbrella. Additionally, the announcement occurred during the anniversary celebration of the Liver and Metabolic Disease Network (InFLiMeN).
Strengthening India’s cellular therapy facility and research
However, the rising burden of metabolic disorders in India presents a major public health challenge. Therefore, Minister Jitendra Singh stressed the importance of focusing on paediatric obesity and early prevention. In addition, the minister expressed full governmental support for the proposed national centre at ILBS.
Collaborative Action Against Metabolic Epidemic
To tackle this growing epidemic, ILBS Director Shiv Kumar Sarin outlined a five-pronged framework. Specifically, this approach focuses on five ‘P’s: Problem, Population, Policies, Physicians, and Products. Meanwhile, Rajesh S Gokhale, Secretary of the Department of Biotechnology, highlighted the value of collaborative, multidisciplinary research. Consequently, former NITI Aayog member Vinod Paul advocated for early-life screening and long-term monitoring. Ultimately, seventeen scientific groups across India committed to collaborate on these critical health issues.
Frequently Asked Questions
Q1: What is the main purpose of the new cellular therapy facility at ILBS?
The facility aims to strengthen advanced translational research and accelerate cell-based therapeutic development in India.
Q2: Why did ILBS propose a national centre for liver and metabolic diseases?
The proposed centre will integrate scientific research, clinical care, public education, and public health initiatives under one umbrella.
Q3: What framework did ILBS Director Shiv Kumar Sarin outline to tackle metabolic diseases?
He introduced a coordinated five-pronged approach focusing on five ‘P’s: Problem, Population, Policies, Physicians, and Products.
References
- Jitendra Singh opens facility for cellular therapy at Institute of Liver & Biliary Sciences – ETHealthworld
- Jitendra Singh opens facility for cellular therapy at Institute of Liver & Biliary Sciences – PTI
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.